Suven Life Sciences Limited (NSE:SUVEN)
India flag India · Delayed Price · Currency is INR
277.70
-2.25 (-0.80%)
Nov 11, 2026, 1:44 PM IST

Suven Life Sciences Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
3,33182.79150.26149.32370.1952.74
Short-Term Investments
136.983,292227.011,4901,451-
Trading Asset Securities
-1,807222.79759.35463.39451.62
Cash & Short-Term Investments
3,4685,181600.052,3992,284504.36
Cash Growth
34.66%763.44%-74.98%5.01%352.91%8.80%
Accounts Receivable
15.1215.0813.3612.868.0712.98
Other Receivables
139.5756.5212.6622.0247.6775.25
Receivables
154.6971.6126.0234.8855.7488.23
Inventory
1.0653.132.387.080.080.33
Prepaid Expenses
-9.4110.025.93.574.33
Other Current Assets
209.66151.86116.26120.19172.1968.7
Total Current Assets
3,8335,467754.722,5672,516665.95
Property, Plant & Equipment
1,185764.47594.82280.1370.16408.91
Long-Term Investments
-8.750.49-1,000-
Other Intangible Assets
1.321.451.811.991.982.25
Other Long-Term Assets
44.490.39-0.211.13.25
Total Assets
5,0646,2421,3522,8493,8891,080

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
35.5648.1352.2720.6816.6519.87
Accrued Expenses
24.9679.69182.59106.9182.4840.19
Current Portion of Long-Term Debt
-----4.84
Current Portion of Leases
46.6345.49-7.110.2611.51
Current Unearned Revenue
-----0.56
Other Current Liabilities
288.0414.21-0.471.916.18
Total Current Liabilities
395.18187.52234.86135.16111.383.15
Long-Term Leases
113.62121.45--5.7915.73
Pension & Post-Retirement Benefits
-0.63--3.777.97
Other Long-Term Liabilities
19.4518.5517.1113.4615.0512.05
Total Liabilities
528.25328.14251.97148.62135.91118.89

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
282.56263.72218.07218.07218.07145.38
Additional Paid-In Capital
-12,4526,4686,4686,4682,566
Retained Earnings
--8,339-5,573-3,965-2,914-1,733
Comprehensive Income & Other
4,2531,537-12.91-20.42-18.99-17.46
Shareholders' Equity
4,5365,9141,1002,7003,753961.45
Total Liabilities & Equity
5,0646,2421,3522,8493,8891,080

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
160.25166.94-7.116.0532.09
Net Cash (Debt)
3,3075,014600.052,3922,268472.27
Net Cash Growth
28.44%735.62%-74.91%5.44%380.28%13.55%
Net Cash Per Share
13.0822.012.7510.9712.723.50
Filing Date Shares Outstanding
283.67263.72218.07218.07218.07145.38
Total Common Shares Outstanding
283.67263.72218.07218.07218.07145.38
Working Capital
3,4385,280519.862,4322,405582.8
Book Value Per Share
15.9922.435.0412.3817.216.61
Tangible Book Value
4,5355,9131,0982,6983,751959.21
Tangible Book Value Per Share
15.9922.425.0412.3717.206.60
Land
-329.29329.293.183.183.18
Machinery
-791.21794.82764.27860.18797.35
Construction In Progress
-35.960.1--35.51